BRIEF published on 11/27/2025 at 20:19, 7 days 9 hours ago Camlin Fine Sciences' strategic acquisition of Vinpai Acquisition Euronext Growth Public Offering Vinpai Camlin Fine Sciences
PRESS RELEASE published on 11/27/2025 at 20:14, 7 days 9 hours ago Inside Information / Other news releases CAMLIN FINE SCIENCES completes acquisition of majority stake in Vinpai, exceeding 50% ownership. Further actions planned per French Stock Markets Authority regulations Acquisition Majority Stake Vinpai Camlin Fine Sciences French Stock Markets Authority
BRIEF published on 11/27/2025 at 19:43, 7 days 10 hours ago Camlin Fine Science acquires a majority stake in Vinpai Acquisition Food Industry Public Offering Vinpai Camlin Fine Science
PRESS RELEASE published on 11/27/2025 at 19:38, 7 days 10 hours ago Inside Information / Other news releases Camlin Fine Science Limited completes acquisition of majority stake in Vinpai, a specialist in algae and plant-based ingredients for food and cosmetics industries. CFSL intends to launch cash tender offer for all outstanding Vinpai shares Majority Stake Cosmetics Industry Vinpai Camlin Fine Science Limited Algae-based Ingredients
BRIEF published on 11/25/2025 at 21:08, 9 days 8 hours ago Timetable Adjustment for Vinpai Block Acquisition Acquisition Convertible Bonds Regulatory Approval Vinpai CFSL
PRESS RELEASE published on 11/25/2025 at 21:03, 9 days 9 hours ago Inside Information / Other news releases CFSL adjusts timetable for Block Acquisition completion date and Vinpai tender offer filing date following regulatory approvals in India. CFSL shareholder approval obtained for issuance of CFSL Consideration Shares at €2.39 per share Shareholder Approval Regulatory Approvals Vinpai CFSL Block Acquisition
BRIEF published on 11/03/2025 at 07:35, 1 month 1 day ago Vinpai suspends its liquidity contract Acquisition Liquidity Vinpai Camlin Functional Ingredients
BRIEF published on 10/20/2025 at 23:48, 1 month 15 days ago Vinpai extends its bond loan with Camlin Convertible Bonds Bond Loan Vinpai Camlin Fine Sciences Extended Maturity
PRESS RELEASE published on 10/20/2025 at 23:43, 1 month 15 days ago Inside Information / Other news releases Camlin Fine Sciences extends convertible bonds financing to Vinpai for €3.3 million, set to mature on Dec 31, 2025, supporting Camlin's acquisition of a majority stake in Vinpai Financing Convertible Bonds Maturity Extension Vinpai Camlin Fine Sciences
BRIEF published on 09/29/2025 at 19:45, 2 months 5 days ago Camlin Fine Sciences Announces Shareholders' Meeting for Vinpai Acquisition Convertible Bonds Shareholders Meeting Stock Market Regulation Camlin Fine Sciences Vinpai Acquisition
Published on 12/05/2025 at 02:35, 3 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 53 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 3 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
